Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)
November 24 2021 - 12:04PM
Edgar (US Regulatory)
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
Form 6-K
REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR
15d-16
UNDER THE SECURITIES EXCHANGE ACT OF 1934
For the
month of November 2021
Commission
File Number 001-15170
GlaxoSmithKline plc
(Translation
of registrant's name into English)
980 Great West Road, Brentford, Middlesex, TW8 9GS
(Address
of principal executive office)
Indicate
by check mark whether the registrant files or will file annual
reports under cover of Form 20-F or Form 40-F.
Form
20-F . . . .X. . . . Form 40-F . . . . . . . .
Indicate
by check mark if the registrant is submitting the Form 6-K in paper
as permitted by Regulation S-T Rule 101(b)(1): ____
Indicate
by check mark if the registrant is submitting the Form 6-K in paper
as permitted by Regulation S-T Rule 101(b)(7): ____
GlaxoSmithKline plc
GSK publishes provisional dividend dates
GSK announces the following dividend dates for
2022:
|
Results
|
Announcement date
|
Ex-dividend date
|
Record date
|
Last date for DRIP elections
|
Payable
|
|
Q1 2022
|
Wednesday
27 April 2022
|
Thursday
19 May 2022
|
Friday
20 May 2022
|
Thursday
16 June 2022
|
Thursday
7 July 2022
|
|
Q2 2022
|
Wednesday
27 July 2022
|
Thursday
18 August 2022
|
Friday
19 August 2022
|
Thursday
15 September 2022
|
Thursday
6 October 2022
|
|
Q3 2022
|
Wednesday
2 November 2022
|
Thursday
17 November 2022
|
Friday
18 November 2022
|
Monday
19 December 2022
|
Thursday
12 January 2023
|
|
Q4 2022
(Final)
|
Wednesday
1 February 2023
|
Thursday
23 February 2023
|
Friday
24 February 2023
|
Tuesday
21 March 2023
|
Thursday
13 April 2023
|
These dates are indicative and may be subject to
change.
V A Whyte
Company Secretary
24 November 2021
SIGNATURES
Pursuant
to the requirements of the Securities Exchange Act of 1934, the
registrant has duly caused this report to be signed on its behalf
by the undersigned, thereunto duly authorised.
|
|
GlaxoSmithKline plc
|
|
|
(Registrant)
|
|
|
|
|
Date: November
24, 2021
|
|
|
|
|
|
|
By:/s/ VICTORIA
WHYTE
--------------------------
|
|
|
|
|
|
Victoria Whyte
|
|
|
Authorised
Signatory for and on
|
|
|
behalf
of GlaxoSmithKline plc
|
GSK (PK) (USOTC:GLAXF)
Historical Stock Chart
From May 2024 to Jun 2024
GSK (PK) (USOTC:GLAXF)
Historical Stock Chart
From Jun 2023 to Jun 2024
